SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001354488-16-006029
Filing Date
2016-01-29
Accepted
2016-01-29 17:04:45
Documents
110
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO QUARTERLY REPORT tbuff_10a.htm 10-Q/A 1697132
2 CONSENT tbuff_ex23.htm EX-23 7530
3 CERTIFICATION tbuff_ex311.htm EX-31.1 9844
4 CERTIFICATION tbuff_ex312.htm EX-31.2 9790
5 CERTIFICATION tbuff_ex321.htm EX-32.1 6287
6 CERTIFICATION tbuff_ex322.htm EX-32.2 5968
7 img001.jpg GRAPHIC 18278
8 img002.jpg GRAPHIC 7339
  Complete submission text file 0001354488-16-006029.txt   7296913

Data Files

Seq Description Document Type Size
9 tbuff-20150630.xml EX-101.INS 1394596
10 tbuff-20150630.xsd EX-101.SCH 79834
11 tbuff-20150630_cal.xml EX-101.CAL 73144
12 tbuff-20150630_def.xml EX-101.DEF 408028
13 tbuff-20150630_lab.xml EX-101.LAB 407138
14 tbuff-20150630_pre.xml EX-101.PRE 442279
Mailing Address 544 EGERTON ST LONDON A6 N5W 3Z8
Business Address 544 EGERTON ST LONDON A6 N5W 3Z8 519-434-1540
Tribute Pharmaceuticals Canada Inc. (Filer) CIK: 0001159019 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-31198 | Film No.: 161374306
SIC: 2834 Pharmaceutical Preparations